ロード中...
Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
Rationale: Interleukin 22 (IL-22) is an epithelial survival cytokine that is at present being explored as therapeutic agents for acute and chronic liver injury. However, its molecular basis of protective activities remains poorly understood. Methods: Here we demonstrate that IL-22 inhibits the deter...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7254999/ https://ncbi.nlm.nih.gov/pubmed/32483425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.43894 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|